SECsense Logo

Cara Therapeutics 8-K Filing Insights - December 2024 Financial Report

$CARA
Form 8-K
Filed on: 2024-12-30
Source
Cara Therapeutics 8-K Filing Insights - December 2024 Financial Report

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Company Information:
  • Entity Name: Cara Therapeutics, Inc.
  • CIK (Central Index Key): 0001346830
  • Location: 400 Atlantic Street, Suite 500, Stamford, CT 06901
  • Phone Number: 203-406-3700
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: December 30, 2024
  • SEC File Number: 001-36279
  • EIN (Employer Identification Number): 75-3175693
  1. Financial Data:
  • Report Period: As of December 30, 2024
  • Currency: USD (United States Dollar)
  • Stock Information:
    • Type: Common Stock
    • Par Value: $0.001 per share
    • Ticker Symbol: CARA
    • Exchange: NASDAQ
  1. Contextual Information:
  • The report appears to be formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial data reporting to enhance transparency and accessibility of financial data.
  1. Measurement Units:
  • The report includes units of measure in both USD and shares, indicating financial metrics may be provided in terms of currency and stock quantity.

This summary encapsulates the essential details from the financial report, focusing on the company, filing specifics, and financial metrics relevant to stakeholders and analysts.